M1A.24
Drug-induced chronic gout, hand
Clinical Classification Guidelines
Medical Intelligence & Overview
Drug-induced chronic gout in the hand is a form of chronic gouty arthritis caused by medications that elevate uric acid levels. Gout is a type of joint inflammation resulting from the buildup of uric acid crystals in the joints. When certain drugs lead to persistent hyperuricemia, gout can develop over time, particularly affecting the small joints of the hand. Recognizing this condition is essential for managing symptoms and preventing joint damage.
Causes & Symptoms
Clinical Causes: Long-term use of medications that increase uric acid levels Diuretics, such as thiazide and loop diuretics Low-dose aspirin therapy Immunosuppressants, like cyclosporine Chemotherapy drugs that affect kidney function Certain anti-rejection medications Medications that impair uric acid excretion
Key Symptoms: Persistent joint pain, especially in the hand Swelling and tenderness around affected joints Redness and warmth in the joint area Limited movement or stiffness in the fingers and hand Formation of tophi (urate crystal deposits under the skin) Recurrent episodes that may worsen over time
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a detailed medical history, including medication use, along with physical examination. Laboratory tests typically reveal elevated serum uric acid levels. Joint aspiration may be performed to identify monosodium urate crystals under a microscope. Imaging studies like X-rays can show joint damage or tophi formation. Recognizing a pattern of chronic joint issues linked to medication use helps confirm drug-induced gout.
Treatment Protocols: Managing drug-induced chronic gout involves multiple approaches: - Adjusting or discontinuing causative medications under medical supervision - Using medications to lower uric acid levels, such as allopurinol or febuxostat - Applying anti-inflammatory drugs to reduce joint inflammation during flare-ups - Maintaining hydration to help eliminate uric acid - Dietary modifications to reduce purine-rich food intake - Regular monitoring of uric acid levels to evaluate treatment effectiveness Long-term management aims to prevent joint damage and improve quality of life by controlling uric acid levels and addressing medication-related causes.
Clinical Advice & FAQs
Billing Guidance
Is M1A.24 a billable ICD-10 code?
Yes, M1A.24 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M1A.24?
Clinical documentation must specify the nature of Drug-induced chronic gout, hand and any associated comorbidities for accurate reporting.
Cite this Clinical Reference